Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Most relevant
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Delayed Xetra  -  11:36 2022-10-05 am EDT
48.65 EUR   +0.01%
10/05Bayer Completes $2.6 Billion Sale of Environmental Science Professional Unit
MT
10/05Bayer : completes sale of its Environmental Science Professional business to Cinven
PU
10/03Optus Confirms More Than Two Million Customers' Identity Documents Affected by Hack
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BAYER AG
10/05Bayer Completes $2.6 Billion Sale of Environmental Science Professional Unit
MT
10/05Bayer : completes sale of its Environmental Science Professional business to Cinven
PU
10/03Optus Confirms More Than Two Million Customers' Identity Documents Affected by Hack
DJ
10/02Optus Hires Deloitte to Review Cyberattack
DJ
10/01Reuters-schedule/…
RE
09/28Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 ..
MT
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
AQ
09/26Australia's No. 2 telco Optus, government clash over massive data breach
RE
09/26U.S. farmers urge Washington to challenge Mexico's looming ban on GM corn
RE
09/26Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
MT
09/24Australia's Optus contacts customers caught in cyber attack
RE
09/22Australia's Optus says up to 10 million customers caught in cyber attack
RE
09/22Optus warns cyberattack may have exposed Australian client details
RE
09/21Singtel's Australian Unit Optus Hit by Cyberattack
DJ
09/20Materials Shares Fall Ahead of Fed Rate Decision -- Materials Roundup
DJ
09/20BAYER AG : Goldman Sachs maintains a Buy rating
MD
09/20BAYER AG : JP Morgan reaffirms its Buy rating
MD
09/20Food Supply Stays Tight as Disappointing U.S. Harvest Adds to Global Challenges -- Comm..
DJ
09/20Syngenta Group Appoints Li Fanrong As Chairman
RE
09/20Biotech corn and soy widely used, consumers still wary of GM wheat
RE
09/20As war, drought hit global crops, Argentina gambles on GM wheat
RE
09/20Fitch Affirms Elanco's IDR at 'BB'; Outlooks Remains Negative
AQ
09/19Environmental groups ask investors to vote against P&G CEO, directors
RE
09/15Bayer CEO says supply shortages cut crop protection sales in 2022
RE
09/15Transcript : Bayer Aktiengesellschaft - Special Call
CI
09/15BAYER AG : Bernstein gives a Buy rating
MD
09/13BAYER AG : Buy rating from Bernstein
MD
09/13Bayer has started search for successor for CEO Baumann -Bloomberg
RE
09/13Germany's Bayer Starts Looking for New CEO
MT
09/13Bayer Begins Search for CEO Werner Baumann's Successor, Bloomberg Reports
DJ
09/13BAYER AG : Bernstein reiterates its Buy rating
MD
09/12MarketScreener's World Press Review : September 12, ..
MS
09/09Health Care Up as Biotech Niche Continues to Gain -- Health Care Roundup
DJ
09/09Bayer AG - Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks i..
AQ
09/08Regeneron Says Aflibercept 8 mg for Diabetic Macular Edema and wAMD Met Primary Endpoin..
MT
09/08Bayer-Regeneron Eye Drug Shows Effect at Higher Doses in Late-Stage Studies
MT
09/08Regeneron Shares Soar on Positive Trial News
DJ
09/08Regeneron Says Retinal Treatment Trials Met Primary Endpoints
DJ
09/05Bayer - Kerendia receives updated label in the U.S. to include findings from Phase III ..
AQ
09/05BAYER AG : UBS remains its Buy rating
MD
09/05Wyld Networks Starts Deployment Of Contact Sensor Developed With Bayer For Beehive Data
MT
09/05Germany's Bayer Enters $40 Million Settlement Deal Over Whistleblower Claims in US
MT
09/02Bayer settles kickback and fraud allegations for $40 million
AQ
09/02Bayer Agrees to $40 Million DOJ Settlement Over Alleged Kickbacks, False Claims
DJ
09/02U.S. says Bayer to pay $40 million to resolve whistleblower lawsuits
RE
09/02U.s. says bayer to pay $40 million to resolve claims over allege…
RE
09/02Bayer Wins US FDA Nod To Add Kidney, Cardiovascular Outcomes In Label For Kerendia
MT
09/02Bayer : Kerendia™ (finerenone) receives updated label in the U.S. to include finding..
PU
09/01Bayer : Kimberly Mathisen appointed to the Supervisory Board of Bayer AG
PU
08/31BAYER AG : Buy rating from Barclays
MD
08/31BAYER AG : Gets a Buy rating from JP Morgan
MD
08/30Bayer Demonstrates Commitment to Advancing Oncology by Showcasing New Data from Innovat..
CI
08/30Syngenta boosts Q2 results ahead of planned IPO
RE
08/29BAYER AG : UBS reaffirms its Buy rating
MD
08/29Bayer's Kerendia Lowers Death Risk in Chronic Kidney Disease, Diabetes Patients
MT
08/29Bayer : New data indicate positive effects of Kerendia™ (finerenone) on mortality in..
PU
08/29BAYER AG : Buy rating from Barclays
MD
08/29BAYER AG : Gets a Buy rating from JP Morgan
MD
08/28Bayer Commences Late-stage Study of Potential Stroke Prevention Drug
MT
08/28BAYER AG : Gets a Buy rating from Jefferies
MD
08/28Bayer Initiates Phase III Study Program for Investigational Oral FXIa Inhibitor Asundex..
CI
08/28Bayer initiates asundexian Phase III study program
RE
08/28Bayer : initiates landmark Phase III study program to investigate oral FXIa inhibitor asun..
PU
08/24BrainVectis, a subsidiary of AskBio, receives clearance to conduct Phase I/II clinical ..
AQ
08/23Bayer Unit Receives Clearance For French Trial Of Huntington's Disease Therapy
MT
08/22BAYER AG : DZ Bank keeps its Buy rating
MD
08/22Bayer : to present data from cardiovascular portfolio, including a late-breaking presentat..
PU
08/19Bayer Showcases Leadership in Breakthrough Innovations and Sustainable, Tailored Soluti..
AQ
08/19Mirena from Bayer approved in the US for extended duration of use in contraception
AQ
08/18Bayer's Intrauterine Contraceptive Wins OK in US for Extended Use Duration
MT
08/18Bayer's Mirena Gets FDA Approval for Extended Use as Contraceptive
DJ
08/18Bayer : Mirena® from Bayer approved in the US for extended duration of use in contraceptio..
PU
08/17Perrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Ov..
MT
08/17GSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on BAYER AG